| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $424K | -64.1% | -82.5% |
| Cost of Revenue | $1.8M | +49.7% | +11.2% |
| Gross Profit | -$1.4M | -5900.0% | -273.6% |
| R&D Expense | $300K | -50.0% | -57.1% |
| SG&A Expense | $674K | -90.4% | +30.1% |
| Operating Income | -$10.1M | -43.0% | -158.6% |
| Pre-tax Income | -$10.8M | -46.5% | -176.6% |
| Net Income | -$10.8M | -46.5% | -176.6% |
| EPS (Basic) | -$0.06 | -50.0% | -50.0% |
| EPS (Diluted) | -$0.06 | -50.0% | -50.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.7M | +18.2% | +457.3% |
| Accounts Receivable | $1.1M | -50.2% | -38.4% |
| Inventory | $4.7M | -3.5% | -1.7% |
| Current Assets | $18.9M | +3.0% | +100.9% |
| Total Assets | $39.3M | +7.4% | +45.9% |
| Current Liabilities | $15.4M | +32.2% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.1M | -134.4% | — |
| Capital Expenditures | $1.7M | +18.3% | — |
| Investing Cash Flow | -$1.7M | -18.3% | — |
| Financing Cash Flow | $19.8M | +94.1% | — |
| Free Cash Flow | -$14.9M | -110.5% | — |
| +354.6% |
| Total Liabilities | $17.0M | +36.9% | +252.6% |
| Stockholders' Equity | $22.3M | -7.8% | +0.8% |